SlideShare ist ein Scribd-Unternehmen logo
1 von 6
Tracey Newhall, RN, MSN, OCN
Clinical Research Nurse, Thomas Jefferson University
 Clinical studies are done to add to knowledge base and develop
new therapies and treatments
 Interventional: Clinical trials
 Receive specific interventions according to research protocol created
by investigator
 Interventions may be medical products, such as drugs or devices;
procedures; or changes to participants' behavior, such as diet
 Compare a new medical approach to available standard approach
 Compare to placebo that contains no active ingredients, or to no
intervention
 Compare interventions that are already available to each other
 Observational:
 Review health outcomes in groups of participants
 Participants are not assigned to specific interventions
 Example, investigators may observe a group of older adults to learn
more about the effects of different lifestyles on cardiac health.
 Phase I Trials:
 These first studies in people evaluate
 How a new drug should be given
 How often
 What dose is safe
 Phase I trial usually enrolls only a small number of patients.
 Phase II Trials:
 A Phase II trial continues to test the safety of the drug
 Starts to evaluate how well the new drug works
 Phase II oncology studies usually focus on a particular type of cancer
 Phase III Trials:
 Test a new drug, a new combination of drugs, or a new surgical procedure in
comparison to the current standard or placebo
 Typically assigned to standard group or new group at random (like flipping a coin)
 Often enroll large numbers of people and may be conducted at many doctor's
offices, clinics, and cancer centers nationwide
 Phase IV Trials:
 Purpose is to evaluate side effects, risks, and benefits of a drug over a longer
period of time and in a larger number of people than in a Phase III clinical trial
 Eligibility
 Will I fit the criteria to take part in the study?
 Location of the study
 How often do I need to be at the hospital?
 Ongoing testing during the study and after
 Frequency of treatment, tests and follow-up
after the study is over
 Who will pay for the treatment?
 Tests, office visits
 Travel
 Reimbursement
 Principal Investigator
 In charge of carrying out the clinical trial
 Clinical Research Nurse
 Collects information about baseline medical conditions, side effects, medications
for data collections
 Coordinates testing/schedules
 Refers to social work for assistance
 Emotional, Housing, Travel
 Clinical Research Coordinator/Data Manager
 Inputs data
 Coordinates testing/schedules
 Social Work
 Assists with the psychosocial impact of cancer
 Lab Coordinator
 Processes and ships specimens
 https://clinicaltrials.gov/ct2/about-
studies/learn#WhatIs
 http://hospitals.jefferson.edu/departments-
and-services/cancer-clinical-trials/phases-of-
clinical-trials/

Weitere ähnliche Inhalte

Was ist angesagt?

Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016Dana-Farber Cancer Institute
 
Personalized Medicine in Diagnosis and Treatment of Cancer
Personalized Medicine in Diagnosis and Treatment of Cancer Personalized Medicine in Diagnosis and Treatment of Cancer
Personalized Medicine in Diagnosis and Treatment of Cancer Maryam Rafati
 
Melanoma: Where Do We Go from Here? – Michael A. Davies, MD, PhD
Melanoma: Where Do We Go from Here? – Michael A. Davies, MD, PhDMelanoma: Where Do We Go from Here? – Michael A. Davies, MD, PhD
Melanoma: Where Do We Go from Here? – Michael A. Davies, MD, PhDMelanoma Research Foundation
 
What's New in Research for ER+ Metastatic Breast Cancer
What's New in Research for ER+ Metastatic Breast CancerWhat's New in Research for ER+ Metastatic Breast Cancer
What's New in Research for ER+ Metastatic Breast CancerDana-Farber Cancer Institute
 
DDI studies in humans
DDI studies in humans DDI studies in humans
DDI studies in humans GovindMishra61
 
The Latest Treatments for HER2-Positive Breast Cancer
The Latest Treatments for HER2-Positive Breast CancerThe Latest Treatments for HER2-Positive Breast Cancer
The Latest Treatments for HER2-Positive Breast CancerDana-Farber Cancer Institute
 
CNS metastases in Her2+ mBC: does size matter?
CNS metastases in Her2+ mBC: does size matter?CNS metastases in Her2+ mBC: does size matter?
CNS metastases in Her2+ mBC: does size matter?Mauricio Lema
 
Opportunities for Immune Therapy and Prevention
Opportunities for Immune Therapy and PreventionOpportunities for Immune Therapy and Prevention
Opportunities for Immune Therapy and Preventionbkling
 
Personalized medicine in pediatric cancer
Personalized medicine in pediatric cancerPersonalized medicine in pediatric cancer
Personalized medicine in pediatric cancerAmir Abbas Hedayati Asl
 
Clinical Trials for Metastatic Breast Cancer
Clinical Trials for Metastatic Breast CancerClinical Trials for Metastatic Breast Cancer
Clinical Trials for Metastatic Breast Cancerbkling
 
Metronomic Chemotherapy
Metronomic ChemotherapyMetronomic Chemotherapy
Metronomic ChemotherapySonali Karekar
 
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...Dana-Farber Cancer Institute
 
Translation of Orphan DiseaseTrial Design into General Drug Development
Translation of Orphan DiseaseTrial Design into General Drug DevelopmentTranslation of Orphan DiseaseTrial Design into General Drug Development
Translation of Orphan DiseaseTrial Design into General Drug DevelopmentE. Dennis Bashaw
 
Side Effects Management for the Ovarian Cancer Community
Side Effects Management for the Ovarian Cancer CommunitySide Effects Management for the Ovarian Cancer Community
Side Effects Management for the Ovarian Cancer Communitybkling
 
First immunotherapy for early stage triple-negative breast cancer
First immunotherapy for early stage triple-negative breast cancerFirst immunotherapy for early stage triple-negative breast cancer
First immunotherapy for early stage triple-negative breast cancerDoriaFang
 
Surviving and Thriving with Gynecologic Cancer - 9.29.18
Surviving and Thriving with Gynecologic Cancer - 9.29.18Surviving and Thriving with Gynecologic Cancer - 9.29.18
Surviving and Thriving with Gynecologic Cancer - 9.29.18Summit Health
 
Dr arun Triple Negative Breast cancer Presentation
Dr arun Triple Negative Breast cancer PresentationDr arun Triple Negative Breast cancer Presentation
Dr arun Triple Negative Breast cancer PresentationArun Shahi MD,MPH
 

Was ist angesagt? (20)

Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
Dana-Farber Cancer Institute Metastatic Breast Cancer Forum 2016
 
Personalized Medicine in Diagnosis and Treatment of Cancer
Personalized Medicine in Diagnosis and Treatment of Cancer Personalized Medicine in Diagnosis and Treatment of Cancer
Personalized Medicine in Diagnosis and Treatment of Cancer
 
Targeting Advanced Triple-Negative Breast Cancer
Targeting Advanced Triple-Negative Breast CancerTargeting Advanced Triple-Negative Breast Cancer
Targeting Advanced Triple-Negative Breast Cancer
 
Melanoma: Where Do We Go from Here? – Michael A. Davies, MD, PhD
Melanoma: Where Do We Go from Here? – Michael A. Davies, MD, PhDMelanoma: Where Do We Go from Here? – Michael A. Davies, MD, PhD
Melanoma: Where Do We Go from Here? – Michael A. Davies, MD, PhD
 
What's New in Research for ER+ Metastatic Breast Cancer
What's New in Research for ER+ Metastatic Breast CancerWhat's New in Research for ER+ Metastatic Breast Cancer
What's New in Research for ER+ Metastatic Breast Cancer
 
DDI studies in humans
DDI studies in humans DDI studies in humans
DDI studies in humans
 
The Latest Treatments for HER2-Positive Breast Cancer
The Latest Treatments for HER2-Positive Breast CancerThe Latest Treatments for HER2-Positive Breast Cancer
The Latest Treatments for HER2-Positive Breast Cancer
 
CNS metastases in Her2+ mBC: does size matter?
CNS metastases in Her2+ mBC: does size matter?CNS metastases in Her2+ mBC: does size matter?
CNS metastases in Her2+ mBC: does size matter?
 
Opportunities for Immune Therapy and Prevention
Opportunities for Immune Therapy and PreventionOpportunities for Immune Therapy and Prevention
Opportunities for Immune Therapy and Prevention
 
What's Hot in Breast Cancer Treatment
What's Hot in Breast Cancer TreatmentWhat's Hot in Breast Cancer Treatment
What's Hot in Breast Cancer Treatment
 
Personalized medicine in pediatric cancer
Personalized medicine in pediatric cancerPersonalized medicine in pediatric cancer
Personalized medicine in pediatric cancer
 
Clinical Trials for Metastatic Breast Cancer
Clinical Trials for Metastatic Breast CancerClinical Trials for Metastatic Breast Cancer
Clinical Trials for Metastatic Breast Cancer
 
What’s New With HER2?
What’s New With HER2?What’s New With HER2?
What’s New With HER2?
 
Metronomic Chemotherapy
Metronomic ChemotherapyMetronomic Chemotherapy
Metronomic Chemotherapy
 
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
What's New in Treatment and Clinical Trials for Advanced Triple-Negative Brea...
 
Translation of Orphan DiseaseTrial Design into General Drug Development
Translation of Orphan DiseaseTrial Design into General Drug DevelopmentTranslation of Orphan DiseaseTrial Design into General Drug Development
Translation of Orphan DiseaseTrial Design into General Drug Development
 
Side Effects Management for the Ovarian Cancer Community
Side Effects Management for the Ovarian Cancer CommunitySide Effects Management for the Ovarian Cancer Community
Side Effects Management for the Ovarian Cancer Community
 
First immunotherapy for early stage triple-negative breast cancer
First immunotherapy for early stage triple-negative breast cancerFirst immunotherapy for early stage triple-negative breast cancer
First immunotherapy for early stage triple-negative breast cancer
 
Surviving and Thriving with Gynecologic Cancer - 9.29.18
Surviving and Thriving with Gynecologic Cancer - 9.29.18Surviving and Thriving with Gynecologic Cancer - 9.29.18
Surviving and Thriving with Gynecologic Cancer - 9.29.18
 
Dr arun Triple Negative Breast cancer Presentation
Dr arun Triple Negative Breast cancer PresentationDr arun Triple Negative Breast cancer Presentation
Dr arun Triple Negative Breast cancer Presentation
 

Andere mochten auch

Understanding a Cluster of Uveal Melanoma Cases: Update from Huntersville, NC
Understanding a Cluster of Uveal Melanoma Cases: Update from Huntersville, NC Understanding a Cluster of Uveal Melanoma Cases: Update from Huntersville, NC
Understanding a Cluster of Uveal Melanoma Cases: Update from Huntersville, NC Melanoma Research Foundation
 
Prognosis and Medical Oncology Follow-up of Uveal Melanoma
Prognosis and Medical Oncology Follow-up of Uveal MelanomaPrognosis and Medical Oncology Follow-up of Uveal Melanoma
Prognosis and Medical Oncology Follow-up of Uveal MelanomaMelanoma Research Foundation
 
Keeping Our Eyes on a Cure: Patients as Leaders and Advocates
Keeping Our Eyes on a Cure: Patients as Leaders and AdvocatesKeeping Our Eyes on a Cure: Patients as Leaders and Advocates
Keeping Our Eyes on a Cure: Patients as Leaders and AdvocatesMelanoma Research Foundation
 
Huntersville Cluster, North Carolina Cluster Update - Michael Brennan, MD
Huntersville Cluster, North Carolina Cluster Update - Michael Brennan, MDHuntersville Cluster, North Carolina Cluster Update - Michael Brennan, MD
Huntersville Cluster, North Carolina Cluster Update - Michael Brennan, MDMelanoma Research Foundation
 
Local Therapies for Uveal Melanoma Liver Metastases
Local Therapies for Uveal Melanoma Liver MetastasesLocal Therapies for Uveal Melanoma Liver Metastases
Local Therapies for Uveal Melanoma Liver MetastasesMelanoma Research Foundation
 
Uveal melanoma and uncommon locations
Uveal melanoma and uncommon locationsUveal melanoma and uncommon locations
Uveal melanoma and uncommon locationsLorenzo Alonso
 
CURE OM Patient Registry Update - Jacqueline Kraska
CURE OM Patient Registry Update - Jacqueline KraskaCURE OM Patient Registry Update - Jacqueline Kraska
CURE OM Patient Registry Update - Jacqueline KraskaMelanoma Research Foundation
 

Andere mochten auch (17)

OM Support Group Details
OM Support Group DetailsOM Support Group Details
OM Support Group Details
 
How Diet Affects Cancer Treatment
How Diet Affects Cancer TreatmentHow Diet Affects Cancer Treatment
How Diet Affects Cancer Treatment
 
Coping During the Holidays
Coping During the HolidaysCoping During the Holidays
Coping During the Holidays
 
Understanding a Cluster of Uveal Melanoma Cases: Update from Huntersville, NC
Understanding a Cluster of Uveal Melanoma Cases: Update from Huntersville, NC Understanding a Cluster of Uveal Melanoma Cases: Update from Huntersville, NC
Understanding a Cluster of Uveal Melanoma Cases: Update from Huntersville, NC
 
Prognosis and Medical Oncology Follow-up of Uveal Melanoma
Prognosis and Medical Oncology Follow-up of Uveal MelanomaPrognosis and Medical Oncology Follow-up of Uveal Melanoma
Prognosis and Medical Oncology Follow-up of Uveal Melanoma
 
Ocular Melanoma Basics
Ocular Melanoma BasicsOcular Melanoma Basics
Ocular Melanoma Basics
 
Emory Eye Tumor SPORE Update - Robin Noe, MD
Emory Eye Tumor SPORE Update - Robin Noe, MDEmory Eye Tumor SPORE Update - Robin Noe, MD
Emory Eye Tumor SPORE Update - Robin Noe, MD
 
Advances in Melanoma Oncology - Mike Atkins, MD
Advances in Melanoma Oncology - Mike Atkins, MDAdvances in Melanoma Oncology - Mike Atkins, MD
Advances in Melanoma Oncology - Mike Atkins, MD
 
Localized Treatment for Metastatic Disease
 Localized Treatment for Metastatic Disease Localized Treatment for Metastatic Disease
Localized Treatment for Metastatic Disease
 
Choroidal melanoma
Choroidal melanomaChoroidal melanoma
Choroidal melanoma
 
Keeping Our Eyes on a Cure: Patients as Leaders and Advocates
Keeping Our Eyes on a Cure: Patients as Leaders and AdvocatesKeeping Our Eyes on a Cure: Patients as Leaders and Advocates
Keeping Our Eyes on a Cure: Patients as Leaders and Advocates
 
Huntersville Cluster, North Carolina Cluster Update - Michael Brennan, MD
Huntersville Cluster, North Carolina Cluster Update - Michael Brennan, MDHuntersville Cluster, North Carolina Cluster Update - Michael Brennan, MD
Huntersville Cluster, North Carolina Cluster Update - Michael Brennan, MD
 
Local Therapies for Uveal Melanoma Liver Metastases
Local Therapies for Uveal Melanoma Liver MetastasesLocal Therapies for Uveal Melanoma Liver Metastases
Local Therapies for Uveal Melanoma Liver Metastases
 
Clinical Trials 101
Clinical Trials 101Clinical Trials 101
Clinical Trials 101
 
Uveal melanoma and uncommon locations
Uveal melanoma and uncommon locationsUveal melanoma and uncommon locations
Uveal melanoma and uncommon locations
 
Ocular Melanoma and Liver Metastases
Ocular Melanoma and Liver MetastasesOcular Melanoma and Liver Metastases
Ocular Melanoma and Liver Metastases
 
CURE OM Patient Registry Update - Jacqueline Kraska
CURE OM Patient Registry Update - Jacqueline KraskaCURE OM Patient Registry Update - Jacqueline Kraska
CURE OM Patient Registry Update - Jacqueline Kraska
 

Ähnlich wie Clinical trials 101

Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introductionbiinoida
 
Importance of clinical trials in drug discovery
Importance of clinical trials in drug discoveryImportance of clinical trials in drug discovery
Importance of clinical trials in drug discoveryKarunaMane1
 
Clinical research basic things
Clinical research basic thingsClinical research basic things
Clinical research basic thingsSRIJIL SREEDHARAN
 
LBDA: Ask the Expert - Daniel Kaufer Live Webinar June 2016
LBDA: Ask the Expert - Daniel Kaufer Live Webinar June 2016LBDA: Ask the Expert - Daniel Kaufer Live Webinar June 2016
LBDA: Ask the Expert - Daniel Kaufer Live Webinar June 2016wef
 
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...Ruchi Vahi
 
# 1st lect 1 intro to interventional research
# 1st lect 1  intro to interventional research# 1st lect 1  intro to interventional research
# 1st lect 1 intro to interventional researchDr. Eman M. Mortada
 
Clinical trials
Clinical trialsClinical trials
Clinical trialsAmarRaj28
 
Evaluating clinical studies - Drug information
Evaluating clinical studies - Drug informationEvaluating clinical studies - Drug information
Evaluating clinical studies - Drug informationAreej Abu Hanieh
 
About Clinical Trials and Its Potential Benefits of Participating
About Clinical Trials and Its Potential Benefits of ParticipatingAbout Clinical Trials and Its Potential Benefits of Participating
About Clinical Trials and Its Potential Benefits of ParticipatingVial Trials
 
Navigating Patients to Clinical Trials
Navigating Patients to Clinical TrialsNavigating Patients to Clinical Trials
Navigating Patients to Clinical Trialsflasco_org
 
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENTJOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENTPristyn Research Solutions
 
Presentation (1)-1.pptx
Presentation (1)-1.pptxPresentation (1)-1.pptx
Presentation (1)-1.pptxJaibhagwan47
 
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...Bhoj Raj Singh
 
Clinical study emphasizing on phases of clinical trials.
Clinical study emphasizing on phases of clinical trials.Clinical study emphasizing on phases of clinical trials.
Clinical study emphasizing on phases of clinical trials.Radhika Soni
 

Ähnlich wie Clinical trials 101 (20)

Clinical Trials Introduction
Clinical Trials IntroductionClinical Trials Introduction
Clinical Trials Introduction
 
Clinical trial
Clinical trialClinical trial
Clinical trial
 
Importance of clinical trials in drug discovery
Importance of clinical trials in drug discoveryImportance of clinical trials in drug discovery
Importance of clinical trials in drug discovery
 
Clinical research basic things
Clinical research basic thingsClinical research basic things
Clinical research basic things
 
LBDA: Ask the Expert - Daniel Kaufer Live Webinar June 2016
LBDA: Ask the Expert - Daniel Kaufer Live Webinar June 2016LBDA: Ask the Expert - Daniel Kaufer Live Webinar June 2016
LBDA: Ask the Expert - Daniel Kaufer Live Webinar June 2016
 
Cr importance-1
Cr importance-1Cr importance-1
Cr importance-1
 
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
Exploring Clinical Trials: How Research Can Help Us Better Detect, Diagnose, ...
 
Cr importance-1
Cr importance-1Cr importance-1
Cr importance-1
 
# 1st lect 1 intro to interventional research
# 1st lect 1  intro to interventional research# 1st lect 1  intro to interventional research
# 1st lect 1 intro to interventional research
 
Clinical trials
Clinical trialsClinical trials
Clinical trials
 
Clinical trials
Clinical trialsClinical trials
Clinical trials
 
A researcher's guide to understanding clinical trials
A researcher's guide to understanding clinical trials A researcher's guide to understanding clinical trials
A researcher's guide to understanding clinical trials
 
Evaluating clinical studies - Drug information
Evaluating clinical studies - Drug informationEvaluating clinical studies - Drug information
Evaluating clinical studies - Drug information
 
About Clinical Trials and Its Potential Benefits of Participating
About Clinical Trials and Its Potential Benefits of ParticipatingAbout Clinical Trials and Its Potential Benefits of Participating
About Clinical Trials and Its Potential Benefits of Participating
 
Navigating Patients to Clinical Trials
Navigating Patients to Clinical TrialsNavigating Patients to Clinical Trials
Navigating Patients to Clinical Trials
 
A researcher's guide to understanding clinical trials
A researcher's guide to understanding clinical trialsA researcher's guide to understanding clinical trials
A researcher's guide to understanding clinical trials
 
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENTJOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
JOB INTERVIEW QUESTIONS ASKED IN CLINICAL TRIAL MANAGEMENT
 
Presentation (1)-1.pptx
Presentation (1)-1.pptxPresentation (1)-1.pptx
Presentation (1)-1.pptx
 
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
Types of Trials in Medicine, vaccine efficacy or effectiveness trials and rel...
 
Clinical study emphasizing on phases of clinical trials.
Clinical study emphasizing on phases of clinical trials.Clinical study emphasizing on phases of clinical trials.
Clinical study emphasizing on phases of clinical trials.
 

Mehr von Melanoma Research Foundation

Metastatic Uveal Melanoma Treatment - 2019 CURE OM Symposium
Metastatic Uveal Melanoma Treatment - 2019 CURE OM SymposiumMetastatic Uveal Melanoma Treatment - 2019 CURE OM Symposium
Metastatic Uveal Melanoma Treatment - 2019 CURE OM SymposiumMelanoma Research Foundation
 
Uveal Melanoma Liver Metastases - 2019 CURE OM Symposium
Uveal Melanoma Liver Metastases - 2019 CURE OM SymposiumUveal Melanoma Liver Metastases - 2019 CURE OM Symposium
Uveal Melanoma Liver Metastases - 2019 CURE OM SymposiumMelanoma Research Foundation
 
CURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumCURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumMelanoma Research Foundation
 
Targeted Therapy Clinical Trial Update - 2019 CURE OM Symposium
Targeted Therapy Clinical Trial Update - 2019 CURE OM SymposiumTargeted Therapy Clinical Trial Update - 2019 CURE OM Symposium
Targeted Therapy Clinical Trial Update - 2019 CURE OM SymposiumMelanoma Research Foundation
 
Auburn Uveal Melanoma Study - 2019 CURE OM Symposium
Auburn Uveal Melanoma Study - 2019 CURE OM SymposiumAuburn Uveal Melanoma Study - 2019 CURE OM Symposium
Auburn Uveal Melanoma Study - 2019 CURE OM SymposiumMelanoma Research Foundation
 
The Past, Present and Future of Uveal Melanoma - 2019 CURE OM Symposium
The Past, Present and Future of Uveal Melanoma - 2019 CURE OM SymposiumThe Past, Present and Future of Uveal Melanoma - 2019 CURE OM Symposium
The Past, Present and Future of Uveal Melanoma - 2019 CURE OM SymposiumMelanoma Research Foundation
 
Clinical Trials Panel Discussion: 2019 CURE OM Symposium
Clinical Trials Panel Discussion: 2019 CURE OM SymposiumClinical Trials Panel Discussion: 2019 CURE OM Symposium
Clinical Trials Panel Discussion: 2019 CURE OM SymposiumMelanoma Research Foundation
 
A Potential Molecular Target for the Treatment of Uveal Melanoma
A Potential Molecular Target for the Treatment of Uveal MelanomaA Potential Molecular Target for the Treatment of Uveal Melanoma
A Potential Molecular Target for the Treatment of Uveal MelanomaMelanoma Research Foundation
 

Mehr von Melanoma Research Foundation (20)

Ocumel Ireland - 2019 CURE OM Symposium
Ocumel Ireland - 2019 CURE OM SymposiumOcumel Ireland - 2019 CURE OM Symposium
Ocumel Ireland - 2019 CURE OM Symposium
 
OcuMel UK - 2019 CURE OM Symposium
OcuMel UK - 2019 CURE OM SymposiumOcuMel UK - 2019 CURE OM Symposium
OcuMel UK - 2019 CURE OM Symposium
 
Ocumel Canada - 2019 CURE OM Symposium
Ocumel Canada - 2019 CURE OM SymposiumOcumel Canada - 2019 CURE OM Symposium
Ocumel Canada - 2019 CURE OM Symposium
 
2019 CURE OM Symposium
2019 CURE OM Symposium2019 CURE OM Symposium
2019 CURE OM Symposium
 
About CURE OM - 2019 CURE OM Symposium
About CURE OM - 2019 CURE OM SymposiumAbout CURE OM - 2019 CURE OM Symposium
About CURE OM - 2019 CURE OM Symposium
 
Metastatic Uveal Melanoma Treatment - 2019 CURE OM Symposium
Metastatic Uveal Melanoma Treatment - 2019 CURE OM SymposiumMetastatic Uveal Melanoma Treatment - 2019 CURE OM Symposium
Metastatic Uveal Melanoma Treatment - 2019 CURE OM Symposium
 
Uveal Melanoma Liver Metastases - 2019 CURE OM Symposium
Uveal Melanoma Liver Metastases - 2019 CURE OM SymposiumUveal Melanoma Liver Metastases - 2019 CURE OM Symposium
Uveal Melanoma Liver Metastases - 2019 CURE OM Symposium
 
CURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM SymposiumCURE OM Patient Registry Update - 2019 CURE OM Symposium
CURE OM Patient Registry Update - 2019 CURE OM Symposium
 
Targeted Therapy Clinical Trial Update - 2019 CURE OM Symposium
Targeted Therapy Clinical Trial Update - 2019 CURE OM SymposiumTargeted Therapy Clinical Trial Update - 2019 CURE OM Symposium
Targeted Therapy Clinical Trial Update - 2019 CURE OM Symposium
 
Unique Populations - 2019 CURE OM Symposium
Unique Populations - 2019 CURE OM SymposiumUnique Populations - 2019 CURE OM Symposium
Unique Populations - 2019 CURE OM Symposium
 
Auburn Uveal Melanoma Study - 2019 CURE OM Symposium
Auburn Uveal Melanoma Study - 2019 CURE OM SymposiumAuburn Uveal Melanoma Study - 2019 CURE OM Symposium
Auburn Uveal Melanoma Study - 2019 CURE OM Symposium
 
The Past, Present and Future of Uveal Melanoma - 2019 CURE OM Symposium
The Past, Present and Future of Uveal Melanoma - 2019 CURE OM SymposiumThe Past, Present and Future of Uveal Melanoma - 2019 CURE OM Symposium
The Past, Present and Future of Uveal Melanoma - 2019 CURE OM Symposium
 
Clinical Trials Panel Discussion: 2019 CURE OM Symposium
Clinical Trials Panel Discussion: 2019 CURE OM SymposiumClinical Trials Panel Discussion: 2019 CURE OM Symposium
Clinical Trials Panel Discussion: 2019 CURE OM Symposium
 
Unique Populations - 2019 CURE OM Symposium
Unique Populations - 2019 CURE OM SymposiumUnique Populations - 2019 CURE OM Symposium
Unique Populations - 2019 CURE OM Symposium
 
Welcome - 2019 CURE OM Symposium
Welcome - 2019 CURE OM SymposiumWelcome - 2019 CURE OM Symposium
Welcome - 2019 CURE OM Symposium
 
Radiology Basics
Radiology BasicsRadiology Basics
Radiology Basics
 
Balancing Work, Life and Melanoma Treatment
Balancing Work, Life and Melanoma TreatmentBalancing Work, Life and Melanoma Treatment
Balancing Work, Life and Melanoma Treatment
 
A Potential Molecular Target for the Treatment of Uveal Melanoma
A Potential Molecular Target for the Treatment of Uveal MelanomaA Potential Molecular Target for the Treatment of Uveal Melanoma
A Potential Molecular Target for the Treatment of Uveal Melanoma
 
Liver Directed Therapies
Liver Directed TherapiesLiver Directed Therapies
Liver Directed Therapies
 
Understanding Scans 101
Understanding Scans 101Understanding Scans 101
Understanding Scans 101
 

Kürzlich hochgeladen

Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfchloefrazer622
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...christianmathematics
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...fonyou31
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 

Kürzlich hochgeladen (20)

Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 

Clinical trials 101

  • 1. Tracey Newhall, RN, MSN, OCN Clinical Research Nurse, Thomas Jefferson University
  • 2.  Clinical studies are done to add to knowledge base and develop new therapies and treatments  Interventional: Clinical trials  Receive specific interventions according to research protocol created by investigator  Interventions may be medical products, such as drugs or devices; procedures; or changes to participants' behavior, such as diet  Compare a new medical approach to available standard approach  Compare to placebo that contains no active ingredients, or to no intervention  Compare interventions that are already available to each other  Observational:  Review health outcomes in groups of participants  Participants are not assigned to specific interventions  Example, investigators may observe a group of older adults to learn more about the effects of different lifestyles on cardiac health.
  • 3.  Phase I Trials:  These first studies in people evaluate  How a new drug should be given  How often  What dose is safe  Phase I trial usually enrolls only a small number of patients.  Phase II Trials:  A Phase II trial continues to test the safety of the drug  Starts to evaluate how well the new drug works  Phase II oncology studies usually focus on a particular type of cancer  Phase III Trials:  Test a new drug, a new combination of drugs, or a new surgical procedure in comparison to the current standard or placebo  Typically assigned to standard group or new group at random (like flipping a coin)  Often enroll large numbers of people and may be conducted at many doctor's offices, clinics, and cancer centers nationwide  Phase IV Trials:  Purpose is to evaluate side effects, risks, and benefits of a drug over a longer period of time and in a larger number of people than in a Phase III clinical trial
  • 4.  Eligibility  Will I fit the criteria to take part in the study?  Location of the study  How often do I need to be at the hospital?  Ongoing testing during the study and after  Frequency of treatment, tests and follow-up after the study is over  Who will pay for the treatment?  Tests, office visits  Travel  Reimbursement
  • 5.  Principal Investigator  In charge of carrying out the clinical trial  Clinical Research Nurse  Collects information about baseline medical conditions, side effects, medications for data collections  Coordinates testing/schedules  Refers to social work for assistance  Emotional, Housing, Travel  Clinical Research Coordinator/Data Manager  Inputs data  Coordinates testing/schedules  Social Work  Assists with the psychosocial impact of cancer  Lab Coordinator  Processes and ships specimens